IL-1RI participates in normal growth plate development and bone modeling

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 1, 2013, Pages

  Simsa Maziel, Stav ^a   Zaretsky, Janna ^a   Reich, Adi ^a   Koren, Yoav ^a   Shahar, Ron ^a   Monsonego Ornan, Efrat ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bone mechanics; Bone structure; Interleukin 1; Interleukin 1 receptor type I; Osteoclasts

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; CYTOKINE PRODUCTION; GROWTH CURVE; GROWTH PLATE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; TRABECULAR BONE;

BONE MECHANICS; BONE STRUCTURE; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR TYPE I; OSTEOCLASTS;

ANIMALS; BONE REMODELING; GROWTH PLATE; HOMEOSTASIS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; PROTEOGLYCANS; RECEPTORS, INTERLEUKIN-1 TYPE I; SIGNAL TRANSDUCTION; TIBIA;

EID: 84879573196     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00335.2012     Document Type: Article

References (46)

1. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6: 183-189, 1991.
2. Bajayo A, Goshen I, Feldman S, Csernus V, Iverfeldt K, Shohami E, Yirmiya R, Bab I. Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci USA 102: 12956-12961, 2005.
3. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125: 1142-1150, 1989.
4. Camplejohn KL, Allard SA. Limitations of safranin 'O' staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies. Histochemistry 89: 185-188, 1988.
5. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475, 1993.
6. Dinarello CA. Biology of interleukin 1. FASEB J 2: 108-115, 1988.
7. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 8: 253-265, 1997.
8. Dinarello CA. Interleukin-1 in disease. Keio J Med 43: 131-136, 1994.
9. Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res 469: 2128-2138, 2011.
10. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132: 195-210, 1996.
11. Funakoshi K, Sugimura K, Anezaki K, Bannai H, Ishizuka K, Asakura H. Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis. Digestion 59: 73-78, 1998.
12. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22: 1197-1207, 2007.
13. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RG. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim Biophys Acta 797: 186-193, 1984.
14. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res 17: 1044-1050, 2002.
15. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140: 4382-4389, 1999.
16. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191: 313-320, 2000.
17. Horowitz MC, Lorenzo J. Local regulators of bone: IL-1, TNF, and lymphotoxin, interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 family and additional cytokines. In: Principals of Bone Biology, edited by Bilezikian J, Raisz L, and Rodan G. San Diego, CA: Academic, 1996, p. 687.
18. Idelevich A, Kerschnitzki M, Shahar R, Monsonego-Ornan E. 1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function. PLoS One 6: e20772, 2012.
19. Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247: 84-93, 1999.
20. Jimi E, Shuto T, Koga T. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology 136: 808-811, 1995.
21. Kato Y, Nakashima K, Iwamoto M, Murakami H, Hiranuma H, Koike T, Suzuki F, Fuchihata H, Ikehara Y, Noshiro M, Jikkot A. Effects of interleukin-1 on syntheses of alkaline phosphatase, type X collagen, and 1,25-dihydroxyvitamin D3 receptor, and matrix calcification in rabbit chondrocyte cultures. J Clin Invest 92: 2323-2330, 1993.
22. Kutukculer N, Caglayan S, Aydogdu F. Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 17: 288-292, 1998.
23. Lee SK, Kalinowski J, Jastrzebski S, Lorenzo JA. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. J Immunol 169: 2374-2380, 2002.
24. Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y. IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 22: 805-816, 2010.
25. Lorenzo JA, Naprta A, Rao Y, Alander C, Glaccum M, Widmer M, Gronowicz G, Kalinowski J, Pilbeam CC. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139: 3022-3025, 1998.
26. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA. Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121: 1164-1170, 1987.
27. MacRae VE, Farquharson C, Ahmed SF. The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol 189: 319-328, 2006.
28. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30: 835-838, 1989.
29. Mainardi GL, Saleri R, Tamanini C, Baratta M. Effects of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, alone or in association with hexarelin or galanin, on growth hormone gene expression and growth hormone release from pig pituitary cells. Horm Res 58: 180-186, 2002.
30. Martensson K, Chrysis D, Savendahl L. Interleukin-1beta and TNFalpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 19: 1805-1812, 2004.
31. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290, 1982.
32. Nakamura I, Jimi E. Regulation of osteoclast differentiation and function by interleukin-1. Vitam Horm 74: 357-370, 2006.
33. Nakamura I, Kadono Y, Takayanagi H, Jimi E, Miyazaki T, Oda H, Nakamura K, Tanaka S, Rodan GA, Duong le T. IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex. J Immunol 168: 5103-5109, 2002.
34. Reich A, Sharir A, Zelzer E, Hacker L, Monsonego-Ornan E, Shahar R. The effect of weight loading and subsequent release from loading on the postnatal skeleton. Bone 43: 766-774, 2008.
35. Sabatini M, Boyce B, Aufdemorte T, Bonewald L, Mundy GR. Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 85: 5235-5239, 1988.
36. Sharir A, Barak MM, Shahar R. Whole bone mechanics and mechanical testing. Vet J 177: 8-17, 2008.
37. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SK. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90: 6155-6159, 1993.
38. Simsa-Maziel S, Monsonego-Ornan E. Interleukin-1β promotes proliferation and inhibits differentiation of chondrocytes through a mechanism involving down-regulation of FGFR-3 and p21. Endocrinology 153: 2296-2310, 2012.
39. Simsa S, Ornan EM. Endochondral ossification process of the turkey (Meleagris gallopavo) during embryonic and juvenile development. Poult Sci 86: 565-571, 2007.
40. Spatz HC, O'Leary EJ, Vincent JF. Young's moduli and shear moduli in cortical bone. Proc Biol Sci 263: 287-294, 1996.
41. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11: 634-640, 1999.
42. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone 14: 595-608, 1993.
43. van der Eerden BC, Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr Rev 24: 782-801, 2003.
44. Walker MB, Kimmel CB. A two-color acid-free cartilage and bone stain for zebrafish larvae. Biotech Histochem 82: 23-28, 2007.
45. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272: 7727-7731, 1997.
46. Zetterström M, Lundkvist J, Malinowsky D, Eriksson G, Bartfai T. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein. Eur Cytokine Netw 9: 131-138, 1998.